Mersana Therapeutics
Harmeet Singh is a Senior Scientist at Mersana Therapeutics since January 2022, with a strong background in pharmaceutical development. Prior to this role, Harmeet gained experience as a Scientist at Bristol Myers Squibb from December 2018 to January 2022, and as a Senior Associate Engineer at Celgene from October 2006 to November 2018, where responsibilities included defining FMEA and executing process characterization studies. Harmeet also worked as an Associate Scientist, focusing on the design and optimization of biologic protein formulations. Educational qualifications include an MBA from the New Jersey Institute of Technology, along with a Bachelor's degree in Biology and a Master's in Public Administration from the University of Illinois Springfield.
This person is not in any teams
Mersana Therapeutics
2 followers
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.